Pharmacist impact on clinical outcome in a diabetes disease management program via collaborative practice

Annals of Pharmacotherapy

Volumn 39, Issue 11, 2005, Pages 1828-1832

  Kiel, Patrick J ^a   McCord, Amie D ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Diabetes mellitus; Disease management; Interdisciplinary care

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; METFORMIN; STATINE DERIVATIVE; SULFONYLUREA DERIVATIVE;

ADULT; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETES MELLITUS; EYE; FEMALE; FOLLOW UP; FOOT; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; PATIENT CARE; PHARMACIST; PHYSICAL EXAMINATION; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

ALBUMINURIA; CHOLESTEROL, HDL; COOPERATIVE BEHAVIOR; DIABETES MELLITUS, TYPE 2; DRUG UTILIZATION REVIEW; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS, LDL; MALE; MEDICAL RECORDS; MIDDLE AGED; MULTICENTER STUDIES; OFFICE VISITS; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; PHYSICIANS, FAMILY; PROFESSIONAL ROLE; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 27344441241     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G356     Document Type: Review

References (20)

1. Janes GR. Ambulatory medical care for diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Diabetes Data Group, 1995:541-52.
2. Jacques CHM, Jones RL, Houts P, Bauer LC, Dwyer KM, Lynch JC, et al. Reported practice behaviors for medical care of patients with diabetes mellitus by primary-care physicians in Pennsylvania. Diabetes Care 1991;14:712-7.
3. Survey of physician practice behaviors related to the treatment of people with diabetes mellitus. Final report. Washington, DC: National Institute of Diabetes and Digestive and Kidney Diseases, 1990.
4. Michigan Diabetes Research and Training Center and Department of Postgraduate Medicine and Health Professional Education: Diabetes in Communities II. Ann Arbor, MI; University of Michigan Medical School, 1992.
5. American Diabetes Association 2005 clinical practice recommendations. Diabetes Care 2005;28(suppl 1):S1-79.
6. Tuttleman M, Lipsett L, Harris MI. Attitudes and behaviors of primary care physicians regarding tight control of blood glucose in IDDM patients. Diabetes Care 1993;16:765-72.
7. Beckles GL, Engelgau MM, Narayan KM, Herman WH, Aubert RE, Williamson DF. Population-based assessment of the level of care among adults with diabetes in the US. Diabetes Care 1998;21:1432-8.
8. Clark C, Snyder J, Meek R, Stutz L, Parkin C. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001;24:1079-86.
9. Kirkman M, Caffrey H, Williams S, Marrero D. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care 2002;25:1946-51.
10. Rothman R, Malone R, Bryant B, Horlen C, Pignone M. Pharmacist-led, primary care-based, disease management improves hemoglobin A1C in high-risk patients with diabetes. Am J Med Qual 2003;18:51-8.
11. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 2000;15:137-42.
12. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32:636-41. DOI 10.1345/aph.17095
13. Cioffi ST, Caron MF, Kalus JS, Hill P, Buckley TE. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. Ann Pharmacotherapy 2004;38:771-5. Epub 2004 Mar 18. DOI 10.1345/aph.1D359
14. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG Jr. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 2002;22:1294-300.
15. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
16. UKPDS Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
17. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
18. Stratum IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
19. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Groghaus L. Effect of improved glycemic control on health care costs and utilization. JAMA 2001;285:182-9.
20. Gilmer TP, O'Connor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care 1997;20:735-44.